Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/ intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang, Ming Zeng, Junmei Jia, Haichuan Su, Yang Song
Release time:
2025-07-08
Source:
Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang, Ming Zeng, Junmei Jia, Haichuan Su, Yang Song, Jie Min, Hongmei Zhang, Wei Li, Hongwei Zhang & Helong Zhang
To cite this article: Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang,Ming Zeng, Junmei Jia, Haichuan Su, Yang Song, Jie Min, Hongmei Zhang, Wei Li, Hongwei
Zhang & Helong Zhang (2023) Hyperthermic intrathoracic/intraperitoneal chemotherapy
versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: amulti-center randomized clinical trial, International Journal of Hyperthermia, 40:1, 2241689, DOI: 10.1080/02656736.2023.2241689
To link to this article: https://doi.org/10.1080/02656736.2023.2241689